Table 2.
Inflammatory and oxidative factors
| Control group | Medium dose group | High dose group | ||
|---|---|---|---|---|
| TNF-α pg/ml ± SD |
0 h |
36.0 ± 12.1 |
37.0 ± 12.2 |
38.1 ± 10.7 |
| 6 h |
37.4 ± 13.2 |
34.5 ± 8.1 |
35.6 ± 15.4 |
|
| 18 h |
35.6 ± 11.6 |
36.38 ± 10.8 |
30.1 ± 7.0 |
|
| 36 h |
36.3 ± 10.9 |
28.6 ± 6.5 |
26.9 ± 7.9 |
|
| FRAP μM ± SD |
0 h |
421. ± 54.5 |
412.3 ± 69.9 |
424.7 ± 71.4 |
| 6 h |
397.1 ± 69.0 |
398.7 ± 73.0 |
427.5 ± 74.6 |
|
| 18 h |
407.7 ± 82.2 |
401.8 ± 90.7 |
452.7 ± 90.8 |
|
| 36 h |
383.4 ± 51.4 |
385.5 ± 53.8 |
490.5 ± 92.5 |
|
| TBARS μM ± SD |
0 h |
4.1 ± 0.7 |
4.3 ± 1.7 |
4.4 ± 1.0 |
| |
6 h |
3.7 ± 0.5 |
4.4 ± 1.0 |
3.9 ± 1.5 |
| |
18 h |
3.9 ± 0.7 |
4.2 ± 1.1 |
3.6 ± 1.2 |
| 36 h | 3.7 ± 0.4 | 4.1 ± 1.4 | 3.0 ± 1.0 |